Physician profile
Nitin Arora
NPI 1659682441
$1,568.62
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $901 · 2020: $99.72 · 2021: $146 · 2022: $145 · 2023: $231 · 2024: $45.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $276.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $663.30 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $186.19 | 2019-2024 | Andexxa |
| Pfizer INC. | $169.42 | 2019-2020 | |
| Abbvie INC. | $121.82 | 2021 | |
| Alkermes, INC. | $120.00 | 2023 | Aristada, Aristada Initio |
| Lilly USA, LLC | $50.94 | 2019 | |
| Biotronik INC. | $40.14 | 2019 | |
| Merck Sharp & Dohme LLC | $39.97 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.32 | 2019 | |
| Amarin Pharma, INC. | $21.67 | 2019 | |
| Indivior INC. | $21.24 | 2019 | |
| Janssen Pharmaceuticals, INC | $20.86 | 2019 | |
| Novo Nordisk INC | $19.67 | 2019 | |
| Allergan, INC. | $19.03 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.25 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $15.12 | 2019 | |
| Edwards Lifesciences Corporation | $14.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nitin Arora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.